Primary Hyperaldosteronism
Primary hyperaldosteronism is a condition where the adrenal glands produce too much aldosterone, leading to high blood pressure and potential electrolyte imbalances.
Primary Aldosteronism: [68Ga]Ga-PentixaFor PET Imaging Study
We are evaluating a new imaging method to help identify how adrenal glands secrete aldosterone in patients with primary aldosteronism. This may improve diagnosis and treatment options for those affected.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Are you pregnant or breastfeeding?
- Do you have primary aldosteronism (a condition where your body makes too much aldosterone)?
- Are you currently using effective contraception if you are a woman of child-bearing age?
- Are you currently participating in another clinical trial?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
PentixaFor
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Assistance Publique Hopitaux De Paris
Hypertension Unit
Issy-les-Moulineaux, France
Assistance Publique Hopitaux De Paris
Department of Nuclear Medicine
Issy-les-Moulineaux, France
Assistance Publique Hopitaux De Paris
Department of Nuclear Medicine
Maison Blanche, France
Sponsor: Assistance Publique Hopitaux De Paris
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.